Methionine Aminopeptidase 2 Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Asieris Pharmaceuticals Co Ltd, Chong Kun Dang Pharmaceutical Corp, Merck KGaA, SynDevRx Inc, Takeda Pharmaceutical Co Ltd, Zafgen Inc

During the projected period of 2021-2027, the Methionine Aminopeptidase 2 Market” research describes in-depth the demand and consumption of numerous products/services connected to market growth dynamics. In terms of quantity, a complete market assessment of the numerous opportunities in the market segment is made. The Methionine Aminopeptidase 2 market is covered several areas, including constraints, problems, and opportunities, as well as geographical considerations. Customers will benefit from this study because it provides historical and statistically significant data, making it both helpful and instructional.

In accordance with the Methionine Aminopeptidase 2 market is set to grow at a CAGR of 6.5% over the forecast period (2021-2027).

Get a Sample PDF Report Here:

Market Overview

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC – Methionine aminopeptidase 2 is an enzyme that in humans is encoded by the METAP2 gene. Methionine aminopeptidase 2 is a member of the dimetallohydrolase family is a cytosolic metalloenzyme that catalyzes the hydrolytic removal of N-terminal methionine residues from nascent proteins. Increased expression of this METAP2 is associated with various forms of cancer, and the anti-cancer drugs fumagillin and ovalicin inhibit the protein by irreversibly binding to its active site. Inhibitors of METAP2 have shown to be effective for the treatment of obesity.

Top Key players operating in the global Methionine Aminopeptidase 2 market is:

Asieris Pharmaceuticals Co Ltd, Chong Kun Dang Pharmaceutical Corp, Merck KGaA, SynDevRx Inc, Takeda Pharmaceutical Co Ltd, Zafgen Inc

Recent Development:

  • Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Takeda now has an attractive, expanded geographic footprint and leading position in Japan and the U.S., bringing its highly innovative medicines to approximately 80 countries/regions with dedicated employees worldwide. Takeda’s R&D efforts are focused on its four therapeutic areas of Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases, with targeted R&D investment also committed to Plasma-Derived Therapies (PDT) and Vaccines.
  • Zafgen, Inc. and Chondrial Therapeutics, Inc., today announced they have entered into a definitive merger agreement under which Chondrial will become a wholly-owned subsidiary of Zafgen and the stockholders of Chondrial Therapeutics will become the majority owners of Zafgen’s outstanding common stock upon the close of the merger. The proposed merger will result in a combined publicly-traded, clinical-stage biopharmaceutical company operating under a new name, Larimar Therapeutics, Inc.

Major Methionine Aminopeptidase 2 Market Types covered are:

  • APL-1301
  • M-8891
  • RSF-101
  • SDX-7195
  • Others

Major Methionine Aminopeptidase 2 Market Applications covered are:

  • Hospital
  • Clinic
  • Others

Access Full Report, here:

Regional Analysis of Global Methionine Aminopeptidase 2 market:

The Methionine Aminopeptidase 2 Market research gives an in-depth analysis of market growth and other factors in key nations (regions), including:

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of the Middle East & Africa)

Buy Report Here:

Table of Contents: Methionine Aminopeptidase 2 Market

Chapter 1: outline of Methionine Aminopeptidase 2 marketplace

Chapter 2: worldwide market reputation and forecast through areas

Chapter 3: worldwide marketplace popularity and forecast by using types

Chapter 4: worldwide marketplace repute and forecast by using Downstream enterprise

Chapter 5: marketplace riding issue evaluation

Chapter 6: market opposition reputation by major producers

Chapter 7: essential producers Presentation and market data

Chapter 8: Upstream and Downstream marketplace investigation

Chapter 9: Fetched and net part investigation

Chapter 10: advertising reputation research

Chapter 11: marketplace file end

Chapter 12: research technique and Reference

Impact of COVID-19 on the Methionine Aminopeptidase 2 Market:

The upward push of COVID-19 has moderated showcase improvement; anyhow, the market is constantly selecting up-tempo due to growing lockdowns. The sudden increment in CAGR is thanks to the request and extension of this marketplace, which is functionality to return to pre-pandemic ranges once the large, is gone.

About Us:

Market intelligence data may be a global front-runner within the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customised research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to:





Leave a Reply

Your email address will not be published. Required fields are marked *